Medical Devices: ECT
UK Mirror, March 2016: “Woman Died After NHS Electric Shock Therapy Was Given Without Consent or Second Opinion” Senior Coroner Derek Winter, expressed concern to the UK Health Secretary about the circumstances that resulted in the death of a mentally ill woman after she was subjected to Electroshock without her…
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.
FDA’s lax approval process for medical devices has shielded surgeons and manufacturers who have made a killing from a lucrative business venture. FDA has even awarded the seal of approval years after the rings were implanted in patients while still in the experimental stage–without their knowledge or informed consent.
Panel Chairman Thomas G. Brott, a neurologist at the Mayo Clinic, said he was amazed that essentially no research had been done on ECT’s effects using functional MRI imaging, repeated brain wave (EEG) studies, or autopsy examinations of patients.
At the end of today’s hearings, an FDA advisory panel will issue recommendations about whether manufacturers of electroconvulsive devices must put their devices to rigorous safety tests or whether they should be reclassified from Class III (high risk) to Class II (moderate risk)> Below are critical comments by Professor John…
"Despite ongoing controversy, there has never been a large-scale, prospective study of the cognitive effects of electroconvulsive therapy (ECT)." Dr. Harold Sackeim, et al, 2007.
It may come as a shock to some of you; but, Electroshock machines have never been tested for safety or efficacy.
Landmark Decision: Jury awards $635,177 Damages for Memory Loss from Electroshock Fri, 8 Jul 2005 Below is a press release by Linda Andre, president of Committee for Truth in Psychiatry (CTIP) about the first ever lawsuit in which a jury found a psychiatrist who referred a patient for intensive electroshock…
An OpEd in The New York Times (below) is trumpeting psychiatry’s latest “cure” for depression: it requires surgical implantation of electrodes in the brain, continued “maintenance” with powerful psychotropic drugs, and it costs $40,000.
On Wednesday, the FDA Pediatric Advisory Committee handed the agency a mixed message regarding warnings about selective list of
psychotropic drugs prescribed for treating ADHD symptoms.
